Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -1.87%52.04B | -4.65%32.37B | 26.64%14.98B | -6.42%68.88B | -3.46%53.03B | -8.51%33.95B | -30.23%11.83B | -13.67%73.6B | -15.07%54.93B | -13.38%37.11B |
| Refunds of taxes and levies | 27.21%13.8M | 158.94%11.71M | 29.36%2.11M | -13.65%8.62M | -19.17%10.85M | -58.39%4.52M | 158.14%1.63M | -95.15%9.98M | -94.76%13.42M | -95.21%10.86M |
| Cash received from interests, fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -69.58%354.5K | -61.46%340K |
| Cash received relating to other operating activities | 32.89%3.08B | 51.67%2.27B | 7.71%732.2M | 51.59%6.55B | -14.87%2.32B | -3.09%1.5B | 0.49%679.79M | 15.04%4.32B | 8.24%2.72B | -24.53%1.54B |
| Cash inflows from operating activities | -0.41%55.13B | -2.25%34.65B | 25.61%15.72B | -3.20%75.44B | -4.00%55.36B | -8.31%35.45B | -29.05%12.51B | -12.65%77.93B | -14.51%57.66B | -14.30%38.66B |
| Goods services cash paid | -2.74%48.07B | -4.67%30.04B | 23.99%14B | -6.68%64.58B | -3.96%49.43B | -8.83%31.51B | -31.57%11.29B | -14.69%69.2B | -16.37%51.46B | -16.61%34.56B |
| Staff behalf paid | 11.56%858.83M | 4.15%623.6M | 6.36%350.24M | -0.31%1.07B | -0.00%769.82M | 14.34%598.78M | 7.99%329.31M | 4.21%1.07B | 3.62%769.83M | -1.59%523.68M |
| All taxes paid | -11.43%2.83B | -9.37%1.95B | -3.43%969.99M | 2.70%4.09B | -0.10%3.2B | -4.02%2.15B | -9.68%1B | 12.73%3.98B | 18.22%3.2B | 18.29%2.24B |
| Net loan and advance increase | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 8.07%-1.51M | -7.76%-1.25M |
| Cash paid for fees and commissions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -36.02%266.52K | -20.27%266.52K |
| Cash paid relating to other operating activities | 56.07%2.63B | 104.43%1.99B | 10.74%476.69M | 98.98%4.98B | 22.62%1.69B | -3.13%973.65M | -29.93%430.44M | 36.60%2.5B | 2.06%1.38B | 5.06%1.01B |
| Cash outflows from operating activities | -1.24%54.4B | -1.79%34.6B | 21.00%15.79B | -2.66%74.72B | -3.05%55.08B | -8.08%35.23B | -29.55%13.05B | -12.28%76.76B | -14.36%56.81B | -14.50%38.32B |
| Net cash flows from operating activities | 164.73%732.55M | -73.97%58.25M | 85.42%-79M | -38.99%715.08M | -67.53%276.71M | -33.65%223.77M | 39.46%-541.77M | -31.35%1.17B | -23.33%852.25M | 16.33%337.26M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -46.24%1.43M | -54.34%1M | 101,763.35%1.7B | -94.24%3.81M | -51.49%2.66M | -43.90%2.19M | -36.29%1.67M | 281.53%66.16M | --5.48M | --3.9M |
| Cash received from returns on investments | 4,616.94%1.42M | --1.11M | --135.44K | -98.29%156K | -99.61%30K | ---- | ---- | 12.71%9.13M | -4.26%7.77M | --7.77M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -98.93%3.03M | -95.80%11.84M | -99.98%46.98K | 277.53%684.21M | 2,377.34%283.8M | 2,534.89%281.72M | 3,062.80%280.59M | 874.36%181.23M | -46.92%11.46M | -20.11%10.69M |
| Cash received relating to other investing activities | --18.52M | --18.52M | ---- | -78.88%3M | ---- | ---- | ---- | --14.21M | ---- | ---- |
| Cash inflows from investing activities | -91.49%24.39M | -88.56%32.47M | 502.74%1.7B | 155.31%691.18M | 1,059.43%286.49M | 1,169.40%283.91M | 2,355.98%282.26M | 514.72%270.72M | -16.79%24.71M | 67.11%22.37M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -43.52%89.67M | -31.77%61.37M | -48.25%32.58M | -53.64%208.18M | -57.70%158.76M | -67.96%89.95M | -70.37%62.95M | -11.43%449.01M | 3.96%375.37M | 7.88%280.73M |
| Cash paid to acquire investments | --300K | ---- | --1.7B | -79.23%7.8M | ---- | ---- | ---- | 200.38%37.55M | -82.60%2.18M | -97.80%275.4K |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --790.68K | --790.68K |
| Cash outflows from investing activities | -43.33%89.97M | -31.77%61.37M | 2,653.36%1.73B | -55.61%215.98M | -58.04%158.76M | -68.08%89.95M | -70.40%62.95M | -6.33%486.56M | 1.27%378.33M | 3.33%281.79M |
| Net cash flows from investing activities | -151.35%-65.58M | -114.90%-28.91M | -114.51%-31.81M | 320.16%475.19M | 136.12%127.73M | 174.77%193.96M | 209.01%219.32M | 54.60%-215.84M | -2.83%-353.63M | -0.03%-259.43M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | -53.41%490K | --490K | --490K | ---- | -99.84%1.05M | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | -53.41%490K | --490K | --490K | ---- | -99.84%1.05M | ---- | ---- |
| Cash from borrowing | -41.92%825.94M | -32.63%607.29M | -99.81%1.83M | -37.79%1.83B | -48.04%1.42B | -51.73%901.45M | -45.37%948.09M | -12.64%2.95B | -18.34%2.74B | -31.88%1.87B |
| Cash inflows from financing activities | -41.94%825.94M | -32.67%607.29M | -99.81%1.83M | -37.80%1.83B | -48.02%1.42B | -51.70%901.94M | -45.37%948.09M | -26.65%2.95B | -31.36%2.74B | -44.71%1.87B |
| Borrowing repayment | 13.45%1.56B | 51.91%1.34B | 884.66%811.53M | -44.87%2.19B | -58.56%1.38B | -54.30%880.71M | -93.77%82.42M | 25.08%3.98B | 13.34%3.33B | -7.47%1.93B |
| Dividend interest payment | -58.82%143.18M | -66.97%94.4M | -54.12%7.89M | 6.91%353.29M | 5.17%347.69M | 8.54%285.82M | -61.89%17.2M | -32.30%330.47M | -31.11%330.59M | 199.77%263.33M |
| -Including:Cash payments for dividends or profit to minority shareholders | 3,599.95%27.74M | ---- | ---- | 126.11%5.87M | -68.96%749.84K | --749.84K | ---- | -85.02%2.59M | -92.52%2.42M | ---- |
| Cash payments relating to other financing activities | 2,417.81%444.67M | 2,499.60%435.86M | --17.43M | -43.41%76.97M | -46.48%17.66M | -49.19%16.77M | ---- | -27.94%136.02M | -80.48%33M | -80.48%33M |
| Cash outflows from financing activities | 23.39%2.15B | 57.87%1.87B | 740.06%836.86M | -40.97%2.62B | -52.74%1.74B | -46.78%1.18B | -92.72%99.62M | 15.22%4.44B | 2.96%3.69B | -4.96%2.22B |
| Net cash flows from financing activities | -312.79%-1.33B | -348.13%-1.26B | -198.42%-835.03M | 47.24%-788.95M | 66.29%-321.2M | 20.95%-281.35M | 130.74%848.47M | -1,018.81%-1.5B | -336.04%-952.85M | -134.29%-355.91M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -572.53%-1.87M | -76.14%287.75K | -135.72%-319.48K | 128.65%3.63M | -90.80%395.21K | -58.62%1.21M | 917.85%894.46K | -89.38%1.59M | -67.51%4.3M | -61.09%2.91M |
| Net increase in cash and cash equivalents | -890.06%-660.76M | -994.87%-1.23B | -279.57%-946.17M | 175.33%404.96M | 118.59%83.63M | 150.00%137.58M | 172.34%526.91M | -138.14%-537.55M | -137.98%-449.92M | -125.57%-275.15M |
| Add:Begin period cash and cash equivalents | 18.68%3.58B | 18.68%3.58B | 13.52%3.4B | -15.22%2.99B | -14.65%3.01B | -14.65%3.01B | -15.22%2.99B | 66.41%3.53B | 66.41%3.53B | 66.41%3.53B |
| End period cash equivalent | -5.85%2.92B | -25.56%2.35B | -30.33%2.45B | 13.52%3.4B | 0.52%3.1B | -3.21%3.15B | 25.60%3.52B | -15.22%2.99B | -6.80%3.08B | 1.82%3.26B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.